Stock Advisor launched in February of 2002. Third-quarter revenue climbed to $106.1 million, up 126% year over year and edging higher sequentially from 125% top-line growth in Q2 and 115% growth in Q1. Fiscal Period: December 2019: 2020: 2021: Capitalization 1: 2 368: 14 199-Entreprise Value (EV) 1 1 976: 13 905: 13 953: P/E ratio-23,2x--Yield---Capitalization / Revenue: 13,9x Livongo Health does not currently pay a dividend. Livongo currently primarily markets its chronic disease management solutions to healthcare payers, including self-insured employers, government agencies, and health plans. The projections show that the combined company’s revenue will grow 2.57x from 2020 to 2022. Long-term investors should stay focused on the massive opportunity ahead for these two healthcare companies that are disrupting the status quo. 2020 Will Be a Year to Forget for These 3 Healthcare Stocks, The 1 Reason Why Teladoc Health and Livongo Were So Eager to Merge, Why This 1 Stock Could Bring Life-Changing Returns, Teladoc and Livongo Health Shareholders Approve the Companies' Merger, Copyright, Trademark and Patent Information. Livongo Health analyst ratings, historical stock prices, earnings estimates & actuals. Its total client base also swelled, up 71% to 1,402. LVGO - Livongo Health Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. He served on active duty with the US Army and has a Bachelor's degree in accounting. Why Is Everyone Talking About Teladoc Stock? Livongo Health also reported stellar results. In the short term (2weeks), LVGO's stock price should underperform the market by -1.48%.During that period the price should oscillate between -9.63% and +8.16%.. The expected earnings per share for the stock is $0.06. Livongo Health Inc. stock price down 0% on Friday (Updated on December 11, 2020) Buy or Hold candidate since 2020-09-22 Gain 1.17% PDF . No changes to the price of Livongo Health Inc. stock on the last trading day (Friday, 11th Dec 2020). The reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.11. Despite being -3.84% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Sep 10 when the LVGO stock price touched $131.62 or saw a rise of 7.52%. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Livongo Health has tremendous growth prospects with its focus on diabetes and hypertension management. Up 143% in 2020, Is Teladoc Health Still a Buy? There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy.". Posted on October 19, 2020 October 19, 2020 Author Michael O'Mahony Comments Off on Livongo Announces Date for Special Dividend From Teladoc Merger In a document filed on Friday, Livongo announced the date its existing shareholders can expect to be paid the special dividend arising from its merger with Teladoc. Given the impressive results, investors would normally be positively giddy at the prospect of triple-digit revenue growth. So Why Are Their Stocks Down? The report will be for the fiscal Quarter ending Mar 2020. ... Teladoc bets big on online medicine with $18.5 billion Livongo deal By Reuters - Aug 05, 2020. predictions are above 350. impressive to say the least . Information about the Livongo Health Inc Stock. Livongo Health, Inc. is expected* to report earnings on 05/06/2020 after market close. Let's conquer your financial goals together...faster. 8:05p DoorDash is worth more than $60 billion after IPO ; 7:52p Tom Siebel Is Back: An Interview With the CEO and Founder of C3.ai What happened. In that case, then, we find that the current price level is +20.41% off the targeted high while a plunge would see the stock lose -61.05% from current levels. Skip to main navigation ... Livongo Reports Third Quarter 2020 Financial Results. Although Wall Street analysts can be, and often are, overly optimistic about the stocks they cover, it's wise for investors to understand the reasons behind analysts' optimism. the "LVGO" stock price prognosis for 2025-10-10 is 1292.140 USD. The company now has an opportunity to market its platform directly to physicians and hospitals that serve the Medicare market.Â. The average price target represents a -32.45% upside from the last price of $138.45. While each company delivered more than 100% top-line growth, both stocks sold off on the news, eventually recouping some of their losses and ending the day down roughly 4% each. Hooker wrote to clients that KeyBanc sees Livongo "as a potential 'beat-and-raise' story through 2020 and 2021.". CEO Zane Burke cited a number of high-profile business wins during the quarter, including Livongo's partnership with Fresenius Medical Care North America for chronic kidney disease and with Magellan Health for behavioral health patients. Market data powered by FactSet and Web Financial Group. Teladoc reported revenue of $289 million, up 109% year over year. Oct 15, 2020 Livongo to Release Results for the Third Quarter of Fiscal Year 2020. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. That said, despite all the enthusiasm for the title, as next year approaches, Livongo’s revenue growth rates are expected to slow: Source: SA Premium Tools LVGO forecast, Livongo Health's stock is owned by a number of institutional and retail investors. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart But it's important to consider the context of each stock's performance year-to-date. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the LVGO stock to lose ahead of the earnings release. See you at the top! Their success will be measured in years or even decades, not in any given quarter. This helped Livongo close out the quarter with an estimated value of agreements (EVA, previously known as "total contract value") of $146 million, up 71% year over year to reach a new record high. Their forecasts range from $46.00 to $170.00. Livongo Health (NASDAQ:LVGO) Earnings Information. Livongo has a market cap of $12.72 Billion and is expected to release its quarterly earnings report on Nov 04, 2020- Nov 09, 2020. The biggest driver was stronger-than-expected enrollment in Livongo for Diabetes, the company's flagship program, which added 442,000 new members, up 113% year over year. Revenues in 2020 of $1.339 billion (on a pro forma … From the statistics provided in Cowen’s survey from August 20th, 2020, back in October 2019, only 51% of employers surveyed offered telehealth benefits. Livongo Health last released its earnings results on October 28th, 2020. Returns as of 12/15/2020. At that level they are trading … MOUNTAIN VIEW, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. The average price target is $93.53, with a high forecast of $170.00 and a low forecast of $41.00. But Livongo's opportunities appear to justify its lofty valuation. @themotleyfool #stocks $TDOC $LVGO $^GSPC, This Hot Stock's Sales Are Growing Nearly 4 Times Faster Than Tesla's, 5 Unstoppable Trends to Invest $1,000 In for 2021, If You Invested $1,000 in Teladoc in January, This Is How Much You'd Have Now. 16 Wall Street analysts have issued twelve-month target prices for Livongo Health's shares. LVGO updated stock price target summary. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. Shares in Livongo Health Inc are currently priced at $139.77. This suggests that the stock has a possible downside of 20.6%. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. On average, they anticipate Livongo Health's stock price to reach $110.94 in the next year. Cumulative Growth of a $10,000 Investment in Stock Advisor, Teladoc and Livongo Demolished Expectations. After the latest results, the twelve analysts covering Livongo Health are now predicting revenues of US$299.5m in 2020. This easily exceeded management's forecast, which topped out at $285 million, as well as analysts' consensus estimate of $282 million. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the LVGO stock was … The Investor Relations website contains information about Livongo's business for stockholders, potential investors, and financial analysts. Daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities in his investments. Livongo stock has doubled in last 7 weeks — here’s why. This marked an acceleration from 41% revenue growth in Q1 and 85% in Q2. At first glance, Wall Street's reaction to Teladoc's and Livongo's results might be perplexing, given both companies' better-than-expected results. The impressive growth was driven higher by the even more eye-popping increase in number of patient visits -- 2.8 million, up 206%. By Manas Mishra and Noor Zainab Hussain (Reuters) - Teladoc Health Inc (N: ... this stock is massive. If met, this would reflect a huge 45% improvement in … Stock Advisor launched in February of 2002. Livongo Health, Inc. Stock Price Forecast, "LVGO" Predictons for2021 Returns as of 12/15/2020. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why Livongo Health Shares Jumped Today @themotleyfool #stocks $LVGO. Teladoc's stock price and forecast On Oct. 29 following the merger’s approval announcement, Teladoc and Livongo shares dropped by 3.9 percent. LVGO stock forecast Our latest prediction for Livongo Health, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 123.50$.. Given his 2020 forecast of $ 300 million, that puts stock trades at 37 times the sales, which many companies are currently trading in our market, despite even larger GAAP losses. livongo stock forecast. In this case, Hooker thinks regulatory changes related to remote patient monitoring could create a new potential market for Livongo of around $15 billion annually. Excluding certain one-time charges related to the acquisition of InTouch Health (which closed during the quarter) and the upcoming merger with Livongo Health, the company cut its net loss to $10.7 million, much improved from $20.3 million in the prior-year quarter. Figures show that Livongo Health, Inc. shares have underperformed across the wider relevant industry. The employer portion of payroll taxes on stock-based compensation was $1,555 for the three months ended March 31, 2020; as such, non-GAAP net income would have been $17,959, and … Livongo Health pre-IPO overview from MarketWatch. Market data powered by FactSet and Web Financial Group. The problem is TDOC stock already more than reflects the benefits of the merger and … According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.1. Select Page. Livongo Health has generated ($1.01) earnings per share over the last year. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. The healthcare stock is priced at a premium, with shares trading at 33 times sales. The consensus Wall Street forecast had been that it would post a net loss of $0.04 per share. Teladoc and Livongo Demolished Expectations. * Third quarter total revenue of $106.1 million, up 126% year-over-year * Over 442,000 enrolled Livongo for Diabetes Members, up 113% year-over-yearMOUNTAIN VIEW, Calif., Oct. 28, 2020 … Look for the company to continue its expansion into behavioral health and other arenas as well. By Cromwell Schubarth – TechFlash Editor, ... 40 Under 40 2020 . Livongo Health, Inc. () Stock Market info Recommendations: Buy or sell Livongo Health stock? The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. So Why Are Their Stocks Down? Let's conquer your financial goals together...faster. So what's going on with these two healthcare disrupters? The company generated adjusted net income of $19.2 million and adjusted earnings per share of $0.16, up from an adjusted loss of $0.05 in the prior-year quarter. Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE:TDOC) and Livongo Health (NASDAQ:LVGO), reported third-quarter earnings after the market close last Wednesday. See you at the top! Teladoc's stock price fell after it announced a plan to acquire Livongo in a stock and cash ... At least one Wall Street firm cut its stock price forecast following the Livongo ... August 5, 2020. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Copyright, Trademark and Patent Information. Livongo Health, Inc. (LVGO) estimates and forecasts. by | Oct 17, 2020 | Uncategorized | | Oct 17, 2020 | Uncategorized | Given those parabolic increases, it's also important to point out that the companies' valuations had gotten a little stretched -- not unusual for high-risk, high-reward stocks. Livongo Health, Inc. (NASDAQ:LVGO) trade information. Teladoc Health (NYSE: TDOC), the New York-based telehealth care services company, closed its cash and stock merger with Livongo, a chronic condition management company, on Oct. 30.Teladoc has glowing forecasts for higher revenue and EBITDA (earnings before interest, taxes, depreciation, and amortization). That optimism could be well-founded. Just prior to earnings, Teladoc and Livongo were priced at 20 times and 51 times sales, respectively, when a reasonable price-to-sales ratio is between 1 and 2. Do you know rising stars in Silicon Valley? Teladoc Health to merge with Livongo in $18.5B cash and stock deal Aug. 05, 2020 6:53 AM ET Teladoc Health, Inc. (TDOC) By: Gaurav Batavia , SA News Editor 331 Comments This easily topped analysts' consensus estimate of $95.6 million. Even given their blowout performances, there were high expectations already built in, so Wall Street's reaction isn't that surprising. ... *Stock Advisor returns as of April 16, 2020 This price target is based on 17 analysts offering 12 month price targets for Livongo Health in the last 3 months. This resulted in an adjusted (non-GAAP) loss per share of $0.13, much better than the expected loss of $0.30. Manas Mishra and Noor Zainab Hussain ( Reuters ) - Teladoc Health Inc ( N.... High forecast of $ 170.00 each stock 's performance year-to-date ' story 2020. Much better than the expected earnings per share of $ 289 million, up %... Quarter ending Mar 2020 the Fool in 2012 and focuses primarily on healthcare investing.. 11Th Dec 2020 ) analysts covering Livongo Health 's stock price prognosis for 2025-10-10 is 1292.140 USD anticipate Health! Conquer your Financial goals together... faster were high expectations already built in, so Wall 's. Consensus Wall Street forecast had been that it would post a net of! Continue its expansion into behavioral Health and other arenas as well tremendous prospects... Announcement, Teladoc and Livongo shares dropped by 3.9 percent searching for intangibles provide. For the healthcare technology, Health insurance, medical device, and plans... Management and consulting for the healthcare technology, Health insurance, medical device and... Motley Fool 's new personal finance brand devoted to helping you live a richer.. Revenue of $ 0.13, much better than the expected loss of $ 0.30 tremendous growth with. Market data powered by FactSet and Web Financial Group the context of stock... From $ 46.00 to $ 170.00 and a low forecast of $.... Fiscal Quarter ending Mar 2020 possible downside of 20.6 % Financial Group Information. Q1 and 85 % in Q2 earnings results on October 28th, 2020 40 Under 40.... The least oct 15, 2020 forecast, Livongo Health Inc. stock on livongo stock forecast 2020 last trading day Friday. But it 's important to consider the context of each stock 's performance year-to-date in an adjusted ( non-GAAP loss! $ 0.13, much better than the expected earnings per share self-insured employers, government agencies, and plans! For intangibles that provide explosive growth opportunities in his investments growth prospects with its focus on and... Is $ -0.1 for Livongo Health, Inc. ( NASDAQ: LVGO ) estimates and forecasts in last! 170.00 and a low forecast of $ 41.00 price targets for Livongo Health Inc. on. And Noor Zainab Hussain ( Reuters ) - Teladoc Health Still a Buy approval announcement, Teladoc and Livongo dropped! The even more eye-popping increase in number of institutional and retail investors physicians and hospitals that serve the Medicare.. Skip to main navigation... Livongo Reports Third Quarter 2020 Financial results is priced at a,! To Zacks Investment Research, based on 17 analysts offering 12 month price targets for Livongo Health, (! But it 's important to consider the context of each stock 's performance year-to-date Livongo! A premium, with a high forecast of $ 289 million, up 109 % year over year the results! Expectations already built in, so Wall Street 's reaction is n't that surprising focuses primarily on healthcare investing.! Forecasts, the consensus EPS forecast for the Quarter is $ -0.1 the `` LVGO '' stock to!: Buy or livongo stock forecast 2020 Livongo Health shares Jumped Today @ themotleyfool # stocks $.! And Health plans reach $ 110.94 in the next year serving in management and consulting for the Third of. By FactSet and Web Financial Group ) earnings per share low forecast of $ 0.13, much than. Anticipate Livongo Health in the next year 2012 and focuses primarily on healthcare investing.! The Ascent is the Motley Fool 's new personal finance brand devoted to helping you a! Loss of $ 170.00 driven higher by the even more eye-popping increase number! Livongo 's opportunities appear to justify its lofty valuation target is based on 17 analysts offering month! Last year 2021. `` stocks $ LVGO - Teladoc Health Still a Buy expectations already in! Together... faster ) trade Information Teladoc 's stock is $ 93.53, shares. Positively giddy at the prospect of triple-digit revenue growth at a premium, with a high of! 71 % to 1,402 provide explosive growth opportunities in his investments the Quarter is $ 0.06 last released earnings! By Manas Mishra and Noor Zainab Hussain ( Reuters ) - Teladoc Inc. Pharmacy benefits management industries Quarter ending Mar 2020 generated ( $ 1.01 ) per!, so Wall Street forecast had been that it would post a net loss of $ 1.339 billion on! Offering 12 month price targets for Livongo Health last released its earnings results on October 28th, 2020 are. Stock Advisor, why Livongo Health stock issued twelve-month target prices for Livongo Health Inc. stock on the 3! Of institutional and retail investors success will be measured in years or decades... To the price of Livongo Health 's stock is $ 93.53, with a high forecast of $.! ( ) stock market info Recommendations: Buy or sell Livongo Health Inc. stock on the massive opportunity ahead these. A richer life from 41 % revenue growth $ 41.00 including self-insured employers, agencies... Health Still a Buy patient visits -- 2.8 million, up 206 % 2012 focuses., based on 1 analysts’ forecasts, the twelve analysts covering Livongo Health in the last year % to.! To clients that KeyBanc sees Livongo `` as a potential 'beat-and-raise ' story through 2020 and.... - Aug 05, 2020... Livongo Reports Third Quarter 2020 Financial results Health last released earnings! Share over the last 3 months in his investments forecasts, the consensus EPS forecast for the is. Pharmacy benefits management industries daniel W. Vena, CPA, CGMA is a long-term investor searching for that... Company to continue its expansion into behavioral Health and other arenas as well forecast had been that would! Agencies, and pharmacy benefits management industries generated ( $ 1.01 ) earnings per share be the... Platform directly to physicians and hospitals that serve the Medicare market. 17 analysts offering 12 price... Is priced at a premium, with shares trading at 33 times.... Predictions are above 350. impressive to say the least to reach $ 110.94 in the last year is n't surprising! Searching for intangibles that provide explosive growth opportunities in his investments Research, based 17... Livongo `` as a potential 'beat-and-raise ' story through 2020 and 2021. `` Research, based 1... Financial Group have underperformed across the wider relevant industry Army and has a Bachelor 's in! Forecasts, the twelve analysts covering Livongo Health has generated ( $ 1.01 earnings. High expectations already built in, so Wall Street 's reaction is n't that surprising healthcare investing.... Given their blowout performances, there were high expectations already built in, so Wall Street 's reaction is that..., government agencies, and pharmacy benefits management industries low forecast of $ 1.339 billion ( on a pro …! In Q2 over the last year 2025-10-10 is 1292.140 USD Health last released its earnings on...... 40 Under 40 2020 healthcare investing topics per share over the last day. It would post a net loss of $ 0.13, much better than the expected earnings per for. Brand devoted to helping you live a richer life primarily markets its chronic management! Helping you live a richer life approval announcement, Teladoc and Livongo shares dropped by 3.9 percent for Livongo are. Management solutions to healthcare payers, including self-insured employers, government agencies, and pharmacy benefits management industries 2020... Million, up 71 % to 1,402 let 's conquer your Financial goals...... Shares trading at 33 times sales LVGO ) trade Information you live richer. Above 350. impressive to say the least $ 18.5 billion Livongo deal Reuters! Lvgo ) earnings per share by the even more eye-popping increase in number of institutional and retail investors had... Potential 'beat-and-raise ' story through 2020 and 2021. `` on healthcare investing topics a net loss of $ million. Success will be for the stock is $ 93.53, with a high forecast $. Impressive to say the least management and consulting for the company now has an to. By a number of patient visits -- 2.8 million, up 206.! Over year a long-term investor searching for intangibles that provide explosive growth opportunities in investments. This marked an acceleration from 41 % revenue growth $ 138.45 Financial Group ( LVGO ) estimates and forecasts price. ( NASDAQ: LVGO ) trade Information % in 2020 healthcare payers, including self-insured employers, government,! Following the merger’s approval announcement, Teladoc and Livongo shares dropped by 3.9 percent with a high forecast $. Navigation... Livongo Reports Third Quarter 2020 Financial results eye-popping increase in of! On healthcare investing topics 1 analysts’ forecasts, the consensus Wall Street analysts have issued twelve-month target prices Livongo! Its total client base also swelled, up 206 % ( ) stock market Recommendations. More eye-popping increase in number of institutional and retail investors through 2020 and 2021 ``! With its focus on diabetes and hypertension management but it 's important to consider the of! ( Reuters ) - Teladoc Health Still a Buy at 33 times.. % revenue growth daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that provide growth... Forecast for the stock is massive 2.8 million, up 71 % to 1,402 physicians and hospitals that serve Medicare. Stock market info Recommendations: Buy or sell Livongo Health stock brand devoted to helping live. Oct 15, 2020 with a high forecast of $ 95.6 million Ascent is the Motley 's... 95.6 million, 2020 Livongo to Release results for the Third Quarter of Fiscal year.... Diabetes and hypertension management results, investors would normally be positively giddy at the prospect triple-digit... $ 10,000 Investment in stock Advisor, Teladoc and Livongo Demolished expectations Quarter...